Glen Eagle Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.84K | Hold |
30
| – | – | ﹤0.01% | 736 |
|
2025
Q1 | $5.1K | Hold |
30
| – | – | ﹤0.01% | 726 |
|
2024
Q4 | $4.99K | Hold |
30
| – | – | ﹤0.01% | 749 |
|
2024
Q3 | $5.16K | Hold |
30
| – | – | ﹤0.01% | 754 |
|
2024
Q2 | $4.62K | Hold |
30
| – | – | ﹤0.01% | 764 |
|
2024
Q1 | $4.61K | Hold |
30
| – | – | ﹤0.01% | 780 |
|
2023
Q4 | $4.74K | Hold |
30
| – | – | ﹤0.01% | 744 |
|
2023
Q3 | $4.39K | Hold |
30
| – | – | ﹤0.01% | 748 |
|
2023
Q2 | $4.6K | Hold |
30
| – | – | ﹤0.01% | 747 |
|
2023
Q1 | $4.65K | Sell |
30
-53
| -64% | -$8.22K | ﹤0.01% | 728 |
|
2022
Q4 | $12.8K | Hold |
83
| – | – | ﹤0.01% | 565 |
|
2022
Q3 | $11K | Buy |
83
+53
| +177% | +$7K | ﹤0.01% | 582 |
|
2022
Q2 | $4.07K | Hold |
30
| – | – | ﹤0.01% | 742 |
|
2022
Q1 | $4.47K | Hold |
30
| – | – | ﹤0.01% | 728 |
|
2021
Q4 | $4.86K | Sell |
30
-225
| -88% | -$36.4K | ﹤0.01% | 716 |
|
2021
Q3 | $42.3K | Hold |
255
| – | – | 0.01% | 405 |
|
2021
Q2 | $44K | Hold |
255
| – | – | 0.01% | 402 |
|
2021
Q1 | $40.9K | Hold |
255
| – | – | 0.01% | 383 |
|
2020
Q4 | $42.8K | Hold |
255
| – | – | 0.02% | 352 |
|
2020
Q3 | $40.1K | Hold |
255
| – | – | 0.02% | 338 |
|
2020
Q2 | $42.8K | Hold |
255
| – | – | 0.02% | 310 |
|
2020
Q1 | $33.4K | Hold |
255
| – | – | 0.02% | 318 |
|
2019
Q4 | $37.9K | Hold |
255
| – | – | 0.02% | 356 |
|
2019
Q3 | $31.6K | Hold |
255
| – | – | 0.02% | 348 |
|
2019
Q2 | $35.9K | Hold |
255
| – | – | 0.02% | 312 |
|
2019
Q1 | $38.5K | Hold |
255
| – | – | 0.03% | 297 |
|
2018
Q4 | $31.7K | Hold |
255
| – | – | 0.03% | 300 |
|
2018
Q3 | $40.4K | Hold |
255
| – | – | 0.03% | 287 |
|
2018
Q2 | $35.7K | Hold |
255
| – | – | 0.03% | 294 |
|
2018
Q1 | $33.9K | Hold |
255
| – | – | 0.03% | 285 |
|
2017
Q4 | $31.8K | Sell |
255
-100
| -28% | -$12.5K | 0.03% | 285 |
|
2017
Q3 | $44K | Buy |
355
+40
| +13% | +$4.96K | 0.04% | 250 |
|
2017
Q2 | $35.9K | Hold |
315
| – | – | 0.03% | 243 |
|
2017
Q1 | $33.2K | Hold |
315
| – | – | 0.03% | 242 |
|
2016
Q4 | $28.6K | Buy |
+315
| New | +$28.6K | 0.03% | 249 |
|